Polyphron
An AI-guided tissue-engineering platform that grows human micro-tissues and models their responses to support drug research and development.
$20MSeed
LeadQC
Quiet Capital
Activity from announced rounds
Activity in this selectionUnited States · Oct 9, 2026 · Sep 10, 2026
Quiet Capital is the venture firm named by RWX and Thatch in their financing announcements.
Recorded funding activity
RWX supplies cloud environments for testing agent-developed software. Thatch manages employee-directed health benefits, while Polyphron develops micro-tissue models for drug research. The company histories preserve these distinct applications.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $128M 2 disclosed · full round size, not this investor’s share